Effect of Mavacamten on Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: The EXPLORER-CN Randomized Clinical Trial

IMPORTANCE: Mavacamten has shown clinical benefits in global studies for patients with obstructive hypertrophic cardiomyopathy (oHCM), but evidence in the Asian population is lacking. OBJECTIVE: To evaluate the safety and efficacy of mavacamten compared with placebo for Chinese patients with symptom...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Zhuang, Li, Liwen, Li, Xiaoyan, Wang, Jian’an, Zhang, Qing, Li, Zhanquan, Peng, Daoquan, Yang, Ping, Ma, Wei, Wang, Fang, Jin, Wei, Cheng, Xiang, Sun, Jing, Fu, Yiqun, Lyu, Cheng, Zhang, Shuyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463173/
https://www.ncbi.nlm.nih.gov/pubmed/37639259
http://dx.doi.org/10.1001/jamacardio.2023.3030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463173/
https://www.ncbi.nlm.nih.gov/pubmed/37639259
http://dx.doi.org/10.1001/jamacardio.2023.3030

Ejemplares similares